Pharmacogn Rev. 2015 Jan-Jun;9(17):63-72. doi: 10.4103/0973-7847.156353.
Echinacea purpurea: Pharmacology, phytochemistry and analysis methods.
Pharmacognosy reviews
Azadeh Manayi, Mahdi Vazirian, Soodabeh Saeidnia
Affiliations
Affiliations
- Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran ; Division of Pharmacy, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada, India.
PMID: 26009695
PMCID: PMC4441164 DOI: 10.4103/0973-7847.156353
Abstract
Echinacea purpurea (Asteraceae) is a perennial medicinal herb with important immunostimulatory and anti-inflammatory properties, especially the alleviation of cold symptoms. The plant also attracted scientists' attention to assess other aspects of its beneficial effects. For instance, antianxiety, antidepression, cytotoxicity, and antimutagenicity as induced by the plant have been revealed in various studies. The findings of the clinical trials are controversial in terms of side effects. While some studies revealed the beneficial effects of the plant on the patients and no severe adverse effects, some others have reported serious side effects including abdominal pain, angioedema, dyspnea, nausea, pruritus, rash, erythema, and urticaria. Other biological activities of the plant such as antioxidant, antibacterial, antiviral, and larvicidal activities have been reported in previous experimental studies. Different classes of secondary metabolites of the plant such as alkamides, caffeic acid derivatives, polysaccharides, and glycoproteins are believed to be biologically and pharmacologically active. Actually, concurrent determination and single analysis of cichoric acid and alkamides have been successfully developed mainly by using high-performance liquid chromatography (HPLC) coupled with different detectors including UV spectrophotometric, coulometric electrochemical, and electrospray ionization mass spectrometric detectors. The results of the studies which were controversial revealed that in spite of major experiments successfully accomplished using E. purpurea, many questions remain unanswered and future investigations may aim for complete recognition of the plant's mechanism of action using new, complementary methods.
Keywords: Analysis methods; Echinacea purpurea; anti-inflammatory; clinical trial; cytotoxic; immunomodulatory; psychotic
References
- Carbohydr Res. 2000 Aug 7;327(4):497-504 - PubMed
- Planta Med. 1984 Oct;50(5):366-75 - PubMed
- Phytother Res. 2010 Nov;24(11):1605-13 - PubMed
- Phytomedicine. 2003 Jan;10(1):66-86 - PubMed
- J Biol Chem. 2003 Oct 3;278(40):38105-8 - PubMed
- Food Chem Toxicol. 2010 May;48(5):1170-7 - PubMed
- Fitoterapia. 2008 Jan;79(1):53-8 - PubMed
- Antimicrob Agents Chemother. 1998 Jan;42(1):140-6 - PubMed
- Antiviral Res. 1998 Aug;39(2):101-11 - PubMed
- Vaccine. 2010 May 21;28(23):3956-62 - PubMed
- Am J Med. 1999 Feb;106(2):138-43 - PubMed
- J Ethnopharmacol. 2007 Mar 1;110(1):148-53 - PubMed
- Phytomedicine. 2008 Aug;15(8):547-54 - PubMed
- Phytomedicine. 2002 Jul;9(5):390-7 - PubMed
- Food Chem Toxicol. 2009 Jun;47(6):1304-10 - PubMed
- Planta Med. 2007 Jun;73(7):615-23 - PubMed
- Genomics. 2006 Dec;88(6):801-8 - PubMed
- Talanta. 2005 Jun 15;66(5):1094-7 - PubMed
- Phytomedicine. 2010 Jul;17(8-9):563-8 - PubMed
- Planta Med. 2000 Apr;66(3):241-4 - PubMed
- Clin Infect Dis. 2005 Mar 15;40(6):807-10 - PubMed
- J Pharm Pharmacol. 2002 Oct;54(10):1379-83 - PubMed
- Daru. 2011;19(3):173-86 - PubMed
- Planta Med. 2002 Sep;68(9):780-3 - PubMed
- J Pharm Pharmacol. 2005 Aug;57(8):929-54 - PubMed
- Planta Med. 1978 Feb;33(1):89-102 - PubMed
- Fertil Steril. 1999 Mar;71(3):517-22 - PubMed
- Daru. 2013 Jul 25;21(1):61 - PubMed
- J Ethnopharmacol. 2012 Oct 11;143(3):914-9 - PubMed
- Arzneimittelforschung. 1991 Oct;41(10):1076-81 - PubMed
- J Natl Cancer Inst. 1989 May 3;81(9):669-75 - PubMed
- Int J Immunopharmacol. 1997 Jul;19(7):371-9 - PubMed
- Int J Immunopharmacol. 1993 Jul;15(5):605-14 - PubMed
- J Chromatogr A. 2003 Jan 31;986(1):73-81 - PubMed
- Planta Med. 1994 Feb;60(1):37-40 - PubMed
- J AOAC Int. 2011 Sep-Oct;94(5):1400-10 - PubMed
- Int Immunopharmacol. 2002 Feb;2(2-3):381-7 - PubMed
- Phytomedicine. 1999 Mar;6(1):1-6 - PubMed
- Oncogene. 1999 Nov 22;18(49):6853-66 - PubMed
- Virol J. 2009 Nov 13;6:197 - PubMed
- Phytochemistry. 2011 Oct;72(14-15):1848-53 - PubMed
- Phytomedicine. 2002 Apr;9(3):249-53 - PubMed
- Exp Gerontol. 2000 Aug;35(5):627-39 - PubMed
- J Chromatogr A. 2002 Feb 1;945(1-2):239-47 - PubMed
- Cell. 1996 Oct 4;87(1):13-20 - PubMed
- Cell Mol Immunol. 2004 Oct;1(5):343-50 - PubMed
- Res Vet Sci. 2011 Aug;91(1):82-5 - PubMed
- Clin Pharmacol Ther. 2004 Jan;75(1):89-100 - PubMed
- Phytomedicine. 2006 Nov;13(9-10):688-94 - PubMed
- Int J Immunopharmacol. 1991;13(1):27-37 - PubMed
- Planta Med. 2001 Dec;67(9):863-4 - PubMed
- J Agric Food Chem. 2000 May;48(5):1466-72 - PubMed
- J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 1;902:151-6 - PubMed
- Phytomedicine. 2005 Sep;12(9):644-7 - PubMed
- FEBS Lett. 2004 Nov 19;577(3):563-9 - PubMed
- J Biol Chem. 2006 May 19;281(20):14192-206 - PubMed
- Nat Immun. 1993 Mar-Apr;12(2):66-78 - PubMed
- Antiviral Res. 1998 Jul;39(1):55-61 - PubMed
- Phytomedicine. 2005 Sep;12(9):625-31 - PubMed
- Planta Med. 2008 May;74(6):633-7 - PubMed
- Int Immunopharmacol. 2009 Jul;9(7-8):850-8 - PubMed
- J Pharm Biomed Anal. 2009 Jul 12;49(5):1141-9 - PubMed
- Pharmacol Rev. 2006 Sep;58(3):389-462 - PubMed
- Planta Med. 2005 Aug;71(8):701-5 - PubMed
- J Assist Reprod Genet. 1999 Feb;16(2):87-91 - PubMed
- Phytomedicine. 2000 Jul;7(4):273-82 - PubMed
- Planta Med. 2002 Jun;68(6):572-4 - PubMed
- J Chromatogr A. 2006 Jan 27;1103(2):219-28 - PubMed
- Drug Discov Today. 2006 Aug;11(15-16):725-32 - PubMed
- J Clin Pharm Ther. 2004 Feb;29(1):7-13 - PubMed
Publication Types